| Title of Invention | AZETIDINE DERIVATIVES AS CCR-3 RECEPTOR ANTAGONISTS |
|---|---|
| Abstract | Compounds of formula I in free or salt form, wherein Ar, X, Y, R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>5</sup>, m, n, p and q have the meaningscas , indicated in the specification, are useful for treating conditions mediated by CCR3. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described. |
| Full Text |
|---|
2026-CHENP-2004 CLAIMS GRANTED.pdf
2026-CHENP-2004 CORRESPONDENCE OTHERS.pdf
2026-CHENP-2004 CORRESPONDENCE PO.pdf
2026-CHENP-2004 DESCRIPTION (COMPLETE) GRANTED.pdf
2026-CHENP-2004 POWER OF ATTORNEY.pdf
| Patent Number | 224473 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indian Patent Application Number | 2026/CHENP/2004 | |||||||||||||||
| PG Journal Number | 49/2008 | |||||||||||||||
| Publication Date | 05-Dec-2008 | |||||||||||||||
| Grant Date | 16-Oct-2008 | |||||||||||||||
| Date of Filing | 10-Sep-2004 | |||||||||||||||
| Name of Patentee | NOVARTIS AG | |||||||||||||||
| Applicant Address | LICHTSTRASSE 35, CH-4056 BASEL, | |||||||||||||||
Inventors:
|
||||||||||||||||
| PCT International Classification Number | A61K31/397 | |||||||||||||||
| PCT International Application Number | PCT/EP03/02715 | |||||||||||||||
| PCT International Filing date | 2003-03-14 | |||||||||||||||
PCT Conventions:
|
||||||||||||||||